DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Toluene is an investigational drug.
There have been 9 clinical trials for Toluene. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Hepatitis, and Leukemia. The leading clinical trial sponsors are National Cancer Institute (NCI), PTS International Inc., and University of Texas Southwestern Medical Center.
Recent Clinical Trials for Toluene
|Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate||First Affiliated Hospital of Zhejiang University||Phase 1|
|A Phase II Study of PTS100 in Primary HCC Patients||Gongwin Biopharm Co., Ltd.||Phase 2|
|A Study of PTS for Patients With Solid Tumors||PTS International Inc.||Phase 1|